DalFort Capital Partners complete sale of VersaFlex to PPG
Get Alerts PPG Hot Sheet
Join SI Premium – FREE
DALLAS, Feb. 26, 2021 /PRNewswire/ -- DalFort Capital Partners ("DFCP") is pleased to announce the successful closing of the sale of its portfolio company, VersaFlex, to PPG (NYSE: PPG).
Headquartered in Kansas City, Kansas, VersaFlex is an industry-leading manufacturer specializing in polyurea, epoxy and polyurethane coatings for water and waste-water infrastructure, flooring, transportation infrastructure, and industrial applications. Since DFCP's initial investment in 2017, the company completed three add-on acquisitions resulting in substantial growth and scale generating revenue in excess of $70 million in 2020.
Morris Wheeler, Chairman of the Board of VersaFlex and DFCP Operating Partner, stated, "We have enjoyed our journey with VersaFlex and are excited for the team as they join PPG. This outstanding outcome is a testament to the VersaFlex team and DalFort's strategy of partnering with business owners and their operating teams to build exceptional companies."
DalFort Capital Partners is a sector-focused investment firm based in Dallas, Texas, specializing in partnering with entrepreneurs and management teams in the lower middle market. We work collaboratively to strengthen a company's strategic and financial position through operational improvements and acquisitions of complementary businesses. We specialize in identifying and executing strategic add-on acquisitions for our portfolio companies that enhance the company's relationship with existing customers and expand its reach into new geographies or market niches.
Lazard Middle Market served as exclusive financial advisor to VersaFlex. Greenberg Traurig, LLP served as VersaFlex's legal counsel.
View original content to download multimedia:http://www.prnewswire.com/news-releases/dalfort-capital-partners-complete-sale-of-versaflex-to-ppg-301236576.html
SOURCE DalFort Capital Partners, LLC
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CLPS Incorporation Sets Industry Benchmark with Completion of AI-Driven Modernization of a 30-Year-Old Legacy Banking System
- Planning for Accelerated Approval: Timing is Everything, Upcoming Webinar Hosted by Xtalks
- FibroBiologics Announces Australian Patent Accepted for Cannabidiol Adjuvant Therapy for the Treatment of Degenerative Disc Disease
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
LazardSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share